Iovance Biotherapeutics
IOVA
#5408
Rank
C$1.39 B
Marketcap
$4.27
Share price
-7.69%
Change (1 day)
-76.80%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2024 (TTM): -C$0.55 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are C$0.16 Billion. , an increase over its 2023 earnings that were of -C$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.57 Billion-14.17%
2023 -C$0.66 Billion15.46%
2022 -C$0.57 Billion16.39%
2021 -C$0.49 Billion30.83%
2020 -C$0.38 Billion26.62%
2019 -C$0.3 Billion61.29%
2018 -C$0.19 Billion38.09%
2017 -C$0.14 Billion73.16%
2016 -C$76.27 Million92.7%
2015 -C$39.58 Million131.17%
2014 -C$17.12 Million-51.71%
2013 -C$35.46 Million6291.81%
2012 -C$0.56 Million
2008 -C$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$50.16 M-108.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$3.08 Million-99.45% Bahamas